LB
34
8
HD
47
-5
PEP
41
6
AVGO
20
-5
FDX
36
-4
JPM
63
-4
KMX
58
3
PVH
52
-3
C
58
-2
PRU
57
-3
NAVI
41
-3
MUR
43
3
DLTR
34
-4
WMT
74
2
ZTS
47
2
BAC
50
-3
QRVO
6
2
MKC
56
8
EL
20
3
AIV
68
-4
LB
34
8
HD
47
-5
PEP
41
6
AVGO
20
-5
FDX
36
-4
JPM
63
-4
KMX
58
3
PVH
52
-3
C
58
-2
PRU
57
-3
NAVI
41
-3
MUR
43
3
DLTR
34
-4
WMT
74
2
ZTS
47
2
BAC
50
-3
QRVO
6
2
MKC
56
8
EL
20
3
AIV
68
-4
Financhill
Back

PROCEPT BioRobotics Vs. Perspective Therapeutics Industry Stock Comparison

Sell
46

PRCT
PROCEPT BioRobotics

Last Price:
94.28
Seasonality Move:
-3.87%
Sell
30

CATX
Perspective Therapeutics

Last Price:
2.99
Seasonality Move:
34.33%
Sell
46
PROCEPT BioRobotics (PRCT) is a Sell

Is PROCEPT BioRobotics a Buy, Sell or Hold?

  • The current PROCEPT BioRobotics [PRCT] share price is $92.70. The Score for PRCT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • PRCT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $6.17. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PRCT Stock Price Chart

What is PROCEPT BioRobotics's stock price today?

  • The PROCEPT BioRobotics share price today is $92.70
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRCT is experiencing slight selling pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $6.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

PRCT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.65 Buy
Relative Strength Index (14 RSI): 56.79 Buy
Chaikin Money Flow: -57847 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (74.72 - 98.38) Buy
Bollinger Bands (100): (64.36 - 86.18) Buy

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.47 Sell
Relative Strength Index (14 RSI): 14.63 Sell
Chaikin Money Flow: -723713 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.98 - 12.88) Sell
Bollinger Bands (100): (10.81 - 14.53) Sell

PRCT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 92.16 Buy
20-day SMA: 91.1 Buy
50-day SMA: 81.88 Buy
200-day SMA: 65.47 Buy
8-day EMA: 92.16 Buy
20-day EMA: 89.57 Buy
50-day EMA: 83.26 Buy
200-day EMA: 67.47 Buy

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.55 Sell
20-day SMA: 10.54 Sell
50-day SMA: 12.08 Sell
200-day SMA: 12.78 Sell
8-day EMA: 8.2 Sell
20-day EMA: 9.96 Sell
50-day EMA: 11.52 Sell
200-day EMA: 11.52 Sell

PROCEPT BioRobotics Earnings Growth & PRCT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $0.37 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

PROCEPT BioRobotics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):